Apr.06 — Noubar Afeyan, co-founder at Moderna Inc and CEO at Flagship Pioneering Inc, discusses the new finding that their Covid-19 vaccine still works at least six months after patients get the second dose. He shares how soon he thinks there will be more data on vaccine for children. Noubar also talks about the new appointments of CEO-partners at his company, Flagship Pioneering. He speaks to Emily Chang on “Bloomberg Technology”.
source
Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.
This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.